Lyfetec, Inc., Formerly Tri-Star Holdings, Inc., Negotiates Important Alliance With Hong Kong Supplier

FT LAUDERDALE, FL--(Marketwire - March 17, 2009) - LyfeTec, Inc. (PINKSHEETS: TSHL) has reached a definitive agreement in principle with a Hong Kong-based supplier for the fulfillment of orders worldwide. The relationship will also serve to embellish the already impressive product line of LyfeTec with a range of third-party items manufactured in Asia.

LyfeTec is finalizing its plans to launch an international sales campaign in June of this year. The Hong Kong relationship will facilitate this launch by providing direct shipment and warehousing for certain screening kits including kits for cancer screening. These kits will be shipped to a base of distributors and customers outside the United States. This move is expected to increase annual international revenues substantially. During the same time period, LyfeTec will proceed with its activities to achieve regulatory compliance with the FDA for over-the-counter sales in the United States.

LyfeTec believes that completion of this initial agreement with the Hong Kong supplier opens a door that will lead to worldwide availability of LyfeTec products and services. Mr. Matteis, the company's CEO, said: "We are establishing a new way for consumers to track and understand their health. Through LyfeTec, families and individuals have the tools to become more directly involved in screening for major illnesses such as cancer, thereby potentially improving outcomes by very early detection and personal responsibility. I would also like to state we are NOT planning a reverse and our share structure is:"

Authorized: 3,800,000,000

TOTAL O/S: 2,603,371,186

Free Trading: 1,682,189,000        RESTRICTED: 921,182,186

Safe Harbor Act Disclaimer: Forward-looking statements in this release are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to certain risks, and uncertainties and actual results could differ from those discussed. This material is information only and is not an offer or solicitation to buy or sell the securities.